Ergoteles’s HUTCHMED HCM Stock Holding History

Ergoteles’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-110,480	Closed	-$1.44M	–	1221
2023 Q1	$1.44M	Sell	110,480 -148,580	-57%	-$2.44M	0.06%	369
2022 Q4	$3.83M	Buy	+259,060	New	+$2.83M	0.14%	147

Other funds holding HCM

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Ergoteles's HCM Position: Q2 2023 in Review

Ergoteles sold out of HUTCHMED (HCM) in Q2 2023, closing a stake of 110,480 shares — an estimated $1.44M sold.

Ergoteles first reported a position in HCM in Q4 2022 and held it in 2 quarters. The position peaked at $3.83M in Q4 2022. 70 funds tracked by Wall St. Rank hold HCM as of Q2 2023.

Ergoteles reported no remaining HUTCHMED position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 110,480 HUTCHMED shares in Q2 2023, an estimated $1.44M.
Ergoteles first reported a position in HUTCHMED in Q4 2022 and held it in 2 quarters.
Ergoteles's HUTCHMED position peaked at $3.83M in Q4 2022.
70 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.